ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

Smokers Who Quit Live Longer Than Those Who Spit-Study

May 25, 2007

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?

January 5, 1996

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980

Follow-up Finds Finasteride Reduces Prostate Cancer Risk Without Affecting Lifespan

August 30, 2013